Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
15.36 EUR | +3.64% | +6.67% | +56.42% |
01:22pm | Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target | MT |
01:22pm | Guggenheim Starts Abivax With Buy Rating, $50 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+56.42% | 995M | |
+1.51% | 42.75B | |
+48.66% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- Abivax Files for Public Offering of American Depositary Shares in US